PEAK6 Investments’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,500
Closed -$158K 4619
2023
Q4
$158K Buy
+11,500
New +$132K ﹤0.01% 3371
2023
Q3
Sell
-6,300
Closed -$107K 4478
2023
Q2
$107K Buy
+6,300
New +$92.4K ﹤0.01% 3208
2022
Q3
Sell
-6,300
Closed -$107K 5907
2022
Q2
$107K Buy
+6,300
New +$38.9K ﹤0.01% 5208

Other funds holding RCEL

PEAK6 Investments's RCEL Position: Q3 2023 in Review

PEAK6 Investments sold out of Avita Medical (RCEL) in Q3 2023, closing a stake of 3,770 shares — an estimated $64.1K sold.

PEAK6 Investments first reported a position in RCEL in Q2 2022 and held it in 2 quarters. The position peaked at $64.1K in Q2 2023. 80 funds tracked by Wall St. Rank hold RCEL as of Q3 2023.

  • PEAK6 Investments reported no remaining Avita Medical position as of Q3 2023 after selling out during the quarter.
  • PEAK6 Investments sold 3,770 Avita Medical shares in Q3 2023, an estimated $64.1K.
  • PEAK6 Investments first reported a position in Avita Medical in Q2 2022 and held it in 2 quarters.
  • PEAK6 Investments's Avita Medical position peaked at $64.1K in Q2 2023.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.